Moderna, Humana and Elanco Earnings Previews: What Investors Should Watch
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
This report is about the broad US market.
Directly affected
- MRNA Moderna+25.4% 30d
Named in this report.
- HUM Humana+11.5% 30d
Named in this report.
- ELAN Elanco Animal Health-1.4% 19d
Named in this report.
Indirectly affected
- DIA SPDR Dow Jones Industrial Average ETF-0.5% 30d
SPDR Dow Jones Industrial Average ETF: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story.
- QQQ Invesco QQQ-9.8% 30d
Invesco QQQ: it is a broad US stock-market fund. Linked by “investors” (the broad US market) in this story.
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR holds the health sector that Elanco Animal Health belongs to, so it often moves with news about it.
- LLY Eli Lilly and+22.4% 30d
Eli Lilly and is a peer of Elanco Animal Health in pharmaceutical preparations; rivals often move on the same news.
- JNJ Johnson & Johnson-1.7% 30d
Johnson & Johnson is a peer of Elanco Animal Health in pharmaceutical preparations; rivals often move on the same news.
- ABBV AbbVie+7.8% 30d
AbbVie is a peer of Elanco Animal Health in pharmaceutical preparations; rivals often move on the same news.
- MRK Merck+1.9% 18d
Merck is a peer of Elanco Animal Health in pharmaceutical preparations; rivals often move on the same news.
- ABT Abbott Laboratories
Abbott Laboratories is a peer of Elanco Animal Health in pharmaceutical preparations; rivals often move on the same news.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| MRNA | -13.80% | -14.51% | base | after close | after close | after close | after close |
| HUM | -0.22% | -1.75% | base | after close | after close | after close | after close |
| ELAN | -8.16% | -4.84% | base | after close | after close | after close | after close |
| DIA | -1.93% | -2.58% | base | after close | after close | after close | after close |
| QQQ | +3.43% | -1.51% | base | after close | after close | after close | after close |
| XLV | -2.96% | -2.66% | base | after close | after close | after close | after close |
| LLY | -3.15% | -0.45% | base | after close | after close | after close | after close |
| JNJ | -0.43% | -2.09% | base | after close | after close | after close | after close |
| ABBV | -1.41% | -2.06% | base | after close | after close | after close | after close |
| MRK | -2.69% | -1.28% | base | after close | after close | after close | after close |
| ABT | -9.53% | -4.57% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Moderna, Humana and Elanco Earnings Previews: What Investors Should Watch 24/7 Wall St.
Source: 24/7 Wall St.
This story
| Company | When | Move | Status |
|---|---|---|---|
| ABBV | three days earlier | -2.06% | final price |
| ABBV | five days earlier | -1.41% | final price |
| ABT | three days earlier | -4.57% | final price |
| ABT | five days earlier | -9.53% | final price |
| DIA | three days earlier | -2.58% | final price |
| DIA | five days earlier | -1.93% | final price |
| ELAN | three days earlier | -4.84% | final price |
| ELAN | five days earlier | -8.16% | final price |
| HUM | three days earlier | -1.75% | final price |
| HUM | five days earlier | -0.22% | final price |
| JNJ | three days earlier | -2.09% | final price |
| JNJ | five days earlier | -0.43% | final price |
| LLY | three days earlier | -0.45% | final price |
| LLY | five days earlier | -3.15% | final price |
| MRK | three days earlier | -1.28% | final price |
| MRK | five days earlier | -2.69% | final price |
| MRNA | three days earlier | -14.51% | final price |
| MRNA | five days earlier | -13.80% | final price |
| QQQ | three days earlier | -1.51% | final price |
| QQQ | five days earlier | +3.43% | final price |
| XLV | three days earlier | -2.66% | final price |
| XLV | five days earlier | -2.96% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Maria Elvira Salazar sold Moderna (MRNA), worth $1,001 - $15,000 on 24 Sep 2026. That is 42 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Moderna (MRNA) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Moderna (MRNA), worth $1,001 - $15,000 on 28 Aug 2026. That is 69 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 36 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 41 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Lloyd Doggett bought Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 8 Sep 2026. That is 58 days before publication. Filed 5 Oct 2026. View the filing.
- Rep. Pete Sessions sold AbbVie (ABBV), worth $15,001 - $50,000 on 14 Sep 2026. That is 52 days before publication. Filed 18 Sep 2026. View the filing.
- Rep. Rohit Khanna sold AbbVie (ABBV) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 62 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 42 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 78 days before publication. Filed 9 Sep 2026. View the filing.
- Rep. Pete Sessions sold Abbott Laboratories (ABT) (held by a spouse), worth $50,001 - $100,000 on 2 Oct 2026. That is 34 days before publication. Filed 27 Oct 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“Moderna, Humana and Elanco Earnings Previews: What Investors Should Watch” scores 12 out of 100. The score uses 1 sources.